Discriminant analysis as a tool to identify compounds with potential as transdermal enhancers

Journal of Pharmacy and Pharmacology

Volumn 57, Issue 11, 2005, Pages 1389-1396

  Pugh, W J ^a   Wong, R ^a   Falson, F ^b   Michniak, B B ^c   Moss, G P ^c,d  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITÉ LYON 1   (France)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; PROPYLENE GLYCOL; XENOBIOTIC AGENT;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISCRIMINANT ANALYSIS; ENHANCER REGION; MOLECULAR WEIGHT; MOUSE; MULTIPLE REGRESSION; NONHUMAN; STRATUM CORNEUM; ANIMAL; BIOLOGICAL MODEL; DRUG EFFECT; IN VITRO STUDY; INTRADERMAL DRUG ADMINISTRATION; PERMEABILITY; PRINCIPAL COMPONENT ANALYSIS; REGRESSION ANALYSIS; SKIN ABSORPTION; STRUCTURE ACTIVITY RELATION;

ADMINISTRATION, CUTANEOUS; ANIMALS; DISCRIMINANT ANALYSIS; HYDROCORTISONE; MICE; MODELS, BIOLOGICAL; PERMEABILITY; PRINCIPAL COMPONENT ANALYSIS; REGRESSION ANALYSIS; SKIN ABSORPTION; STRUCTURE-ACTIVITY RELATIONSHIP; XENOBIOTICS;

EID: 34548079772     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.57.11.0003     Document Type: Article

References (34)

1. Abraham, M. H. (1993) Scales of solute hydrogen-bonding: their construction and application to physicochemical and biochemical processes. Chem. Soc. Rev. 22: 73-83
2. Abraham, M. H., Platts, J. A. (2001) Hydrogen bond structural group constants. J. Org. Chem. 66: 3484-3491
3. Abraham, M. H., Martins, F., Mitchell, R. C. (1997) Algorithms for skin permeability using hydrogen bond descriptors: the problem of steroids. J. Pharm. Pharmacol. 49: 858-865
4. Asbill, C. S., Michniak, B. B. (2000) Percutaneous penetration enhancers: local versus transdermal activity. Pharm. Sci. Tech. Today 3: 36-41
5. Buchwald, P., Bodor, N. (2001) A simple, predictive, structure-based skin permeability. J. Pharm. Pharmacol. 53: 1087-1098
6. Cronin, M. T. D., Dearden, J. C., Moss, G. P., Murray-Dickson, G. (1999) Investigation of the mechanism of flux across human skin in vitro by quantitative structure activity relationships. Eur. J. Pharm. Sci. 7 325-330
7. Fedors, R. F. (1974) A method for estimating both the solubility parameters and molar volumes of liquids. Polym. Eng. Sci. 14: 147-154
8. Garg, R., Kurup, A., Mekapati, S. B., Hansch, C. (2003) Searching for allosteric effects via QSAR. Part II. Bioorg. Med. Chem. 11: 621-628
9. Ghafourian, T., Zandasrar, P., Hamishekar, H., Nokhodchi, A. (2004) The effect of penetration enhancers on drug delivery through skin: a QSAR study. J. Control. Release 99: 113-125
10. Ghosh, T. K., Pfister, W. Yum, S. I. (1997) Transdermal and topical delivery systems. Interpharm Press, Buffalo Grove, IL, USA
11. Godwin, D. A., Michniak, B. B., Player, M. R., Sowell Sr., J. W. (1997) Transdermal and dermal enhancing activity of pyrrolidinones in hairless mouse skin. Int. J. Pharm. 155: 241-250
12. Godwin, D. A., Player, M. R., Sowell Sr., J. W., Michniak, B. B. (1998) Synthesis and investigation of urea compounds as transdermal penetration enhancers. Int. J. Pharm. 167: 165-175
13. Hansch, C., Garg, R., Kurup, A. (2001) Searching for allosteric effects via QSARs. Bioorg. Med. Chem. 9: 283-289
14. Hansch, C., Garg, R., Kurup, A., Mekapati, S. B. (2003) Allosteric interactions and QSAR: on the role of ligand hydrophobicity. Bioorg. Med. Chem. 11: 2075-2084
15. Hocking, R. R. (1976) A biometrics invited paper: the analysis and selection of variables in linear regression. Biometrics 32: 1-49
16. Kamlet, M. J., Abboud, J.-L. M., Abraham, M. H., Taft, R. W. (1983) Linear solvation energy relationships. 23. A comprehensive collection of the solvatochromic parameters, π*, α, and β, and some methods for simplifying the generalized solvatochromic equation. J. Org. Chem. 48: 2877-2887
17. Katz, M., Poulsen, B. J. (1972) Corticoid, vehicle and skin interactions in percutaneous absorption. J. Soc. Cos. Chem. 23: 565-590
18. Kim, N., El-Khalili, M., Henary, M. M., Strekowski, L., Michniak, B. B. (1999) Percutaneous penetration enhancement activity of aromatic S, S-dimethyliminosulfuranes. Int. J. Pharm. 187: 219-229
19. Kim, N., El-Kattan, A. F., Asbill, C. S., Kennette, R. J., Sowell Sr., J. W., Latour, R., Michniak, B. B. (2001) Evaluation of derivatives of 3-(2-oxo-1-pyrrolidine) hexahydro-1H-azepine-2-one as dermal penetration enhancers: side chain length variation and molecular modelling. J. Control. Release 73: 183-196
20. Lim, C. W., Fujiwara, S., Yamashita, F., Hashida, M. (2002) Prediction of human skin permeability using a combination of MO-calculations and artificial neural network. Biol. Pharm. Bull. 25: 361-366
21. Lipinski, C. A., Lombardo, F., Dominy, B. W., Feeney, P. J. (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Delivery Rev. 23: 3-25
22. Magnusson, B. M., Pugh, W. J., Roberts, M. S. (2004) Simple rules defining the potential of compounds for transdermal delivery or toxicity. Pharm. Res. 21: 1047-1054
23. Michniak, B. B., Player, M. R., Godwin, D. A., Lockhart, C. C., Sowell Sr., J. W. (1998) In vitro evaluation of azone analogs as dermal penetration enhancers: V. Miscellaneous compounds. Int. J. Pharm. 161: 169-178
24. Monod, J., Wyman, J., Changeux, J. P. (1965) On the nature of allosteric transitions: a plausible model. J. Mol. Biol. 12: 88-118
25. Moss, G. P., Cronin, M. T. D. (2002) Quantitative structure-permeability relationships for percutaneous absorption: reanalysis of steroid data. Int. J. Pharm. 238: 105-109
26. Moss, G. P., Dearden, J. C., Patel, H., Cronin, M. T. D. (2002) Quantitative Structure-Permeability Relationships (QSPRs) for percutaneous absorption. Toxicol. In Vitro 16: 299-317
27. Potts, R. O., Guy, R. H. (1992) Predicting skin permeability. Pharm. Res. 9: 663-669
28. Potts, R. O., Guy, R. H. (1995) A predictive algorithm for skin permeability: the effects of molecular size and hydrogen bond activity. Pharm. Res. 12: 1628-1633
29. Pugh, W. J., Hadgraft, J. (1994) Ab initio prediction of human skin permeability coefficient. Int. J. Pharm. 103: 163-178
30. Pugh, W. J., Degim, I. T., Hadgraft, J. (2000) Epidermal permeability-penetrant structure relationships 4. QSAR of permeant diffusion across human stratum corneum in terms of molecular weight. H-bonding and electronic charge. Int. J. Pharm. 197: 203-211
31. st edn, Marcel Dekker, New York, pp 19-23
32. Strekowski, L., Henary, M., Kim, N., Michniak, B. B. (1999) N-(4-Bromobenzoyl)-S, S-dimethyliminosulfurane, a potent dermal penetration enhancer. Bioorg. Med. Chem. Lett. 9: 1033-1034
33. rd edn, Elsevier, Amsterdam, pp 129-159
34. Williams, A. C., Barry, B. W. (2004) Penetration enhancers. Adv. Drug Delivery Rev. 56: 603-618